Atlas Trials

CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases

Clinical trial NCT05827835 · RECRUITING

Trial details

NCT number
NCT05827835
Sponsor
Zhejiang University
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hematologic DiseasesNeoplasms
Start date
2023-04-30
Primary completion
2026-04-25
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.